ロード中...

Bilirubin Nanoparticles Reduce Diet-Induced Hepatic Steatosis, Improve Fat Utilization, and Increase Plasma β-Hydroxybutyrate

The inverse relationship of plasma bilirubin levels with liver fat accumulation has prompted the possibility of bilirubin as a therapeutic for non-alcoholic fatty liver disease. Here, we used diet-induced obese mice with non-alcoholic fatty liver disease treated with pegylated bilirubin (bilirubin n...

詳細記述

保存先:
書誌詳細
出版年:Front Pharmacol
主要な著者: Hinds, Terry D., Creeden, Justin F., Gordon, Darren M., Stec, Donald F., Donald, Matthew C., Stec, David E.
フォーマット: Artigo
言語:Inglês
出版事項: Frontiers Media S.A. 2020
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7775678/
https://ncbi.nlm.nih.gov/pubmed/33390979
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.594574
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!